Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour

Area of Science:

• Neuroscience
• Genetics
• Behavioral Science

Background:

• Anxiety affects up to 40% of Parkinson's disease patients.
• The underlying mechanisms linking Parkinson's disease and anxiety remain largely unknown.
• Alpha-synuclein is a key protein in Parkinson's disease pathogenesis.

Purpose of the Study:

• To investigate the role of alpha-synuclein in anxiety-like behaviors.
• To examine the impact of alpha-synuclein mutations, specifically A53T, on anxiety.
• To explore potential mechanisms connecting alpha-synuclein and anxiety in a preclinical model.

Main Methods:

• Utilized behavioral tests: elevated plus maze and open field test.
• Compared anxiety-like behaviors in mice with varying alpha-synuclein levels.
• Included alpha-synuclein knock-out mice, wild-type controls, and A53T alpha-synuclein transgenic mice.

Main Results:

• Alpha-synuclein A53T transgenic mice displayed significantly reduced anxiety-like behaviors.
• Transgenic mice spent more time in open arms of the elevated plus maze and entered them more frequently.
• A trend towards reduced locomotor habituation and increased thigmotaxis was observed in transgenic mice in the open field test.

Conclusions:

• Alpha-synuclein, particularly the A53T mutation, may be involved in regulating anxiety-like behaviors.
• These findings suggest a potential link between alpha-synuclein dysfunction and anxiety in Parkinson's disease.
• Further research is warranted to elucidate the precise mechanisms.